This is really a case about three cardiology groups that are proposing to merge. One issue is antitrust, and motives and the advantages for the projected merger could be debated.
A second issue is just one of ethics. While the advisor may personally believe that the amalgamation is not wise, her client must be satisfied. Additionally, the Herfindahl-Hirschman Index (HHI) is clarified and suggested as a tool to be used to define market concentrations and identify possible anticompetitive situations.
PUBLICATION DATE: October 08, 2012 PRODUCT #: TCG139-PDF-ENG
This is just an excerpt. This case is about FINANCE & ACCOUNTING
Wheeling Cardiology Associates Case Study Solution
Related Case Solutions & Analyses:
Parkview Foundation
SZLN: Acquiring PEM
Aluminium Bahrain (Alba): The Pot Line 5 Expansion Project
Betting on Gold Using a Futures-Based Gold ETF
White Mountain Health Care
Hanson production: Pricing For Opening Day
Bandon Medical Associates (B)
Is It Time to Rethink Your Pricing Strategy?
Bidding for Finansbank, Chinese Version
Revitalizing State Bank of India
